150 related articles for article (PubMed ID: 26939791)
1. Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2).
Noy PJ; Swain RK; Khan K; Lodhia P; Bicknell R
FASEB J; 2016 Jun; 30(6):2311-23. PubMed ID: 26939791
[TBL] [Abstract][Full Text] [Related]
2. Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth.
Noy PJ; Lodhia P; Khan K; Zhuang X; Ward DG; Verissimo AR; Bacon A; Bicknell R
Oncogene; 2015 Nov; 34(47):5821-31. PubMed ID: 25745997
[TBL] [Abstract][Full Text] [Related]
3. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R
Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670
[TBL] [Abstract][Full Text] [Related]
4. Clec14a is specifically expressed in endothelial cells and mediates cell to cell adhesion.
Rho SS; Choi HJ; Min JK; Lee HW; Park H; Park H; Kim YM; Kwon YG
Biochem Biophys Res Commun; 2011 Jan; 404(1):103-8. PubMed ID: 21095181
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of VEGF-dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a.
Kim TK; Park CS; Jang J; Kim MR; Na HJ; Lee K; Kim HJ; Heo K; Yoo BC; Kim YM; Lee JW; Kim SJ; Kim ES; Kim DY; Cha K; Lee TG; Lee S
Mol Oncol; 2018 Mar; 12(3):356-372. PubMed ID: 29316206
[TBL] [Abstract][Full Text] [Related]
6. Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2.
Pascall JC; Brown KD
Biochem Biophys Res Commun; 2004 Apr; 317(1):244-52. PubMed ID: 15047175
[TBL] [Abstract][Full Text] [Related]
7. Functions of rhomboid family protease RHBDL2 and thrombomodulin in wound healing.
Cheng TL; Wu YT; Lin HY; Hsu FC; Liu SK; Chang BI; Chen WS; Lai CH; Shi GY; Wu HL
J Invest Dermatol; 2011 Dec; 131(12):2486-94. PubMed ID: 21833011
[TBL] [Abstract][Full Text] [Related]
8. Clec14a genetically interacts with Etv2 and Vegf signaling during vasculogenesis and angiogenesis in zebrafish.
Pociute K; Schumacher JA; Sumanas S
BMC Dev Biol; 2019 Apr; 19(1):6. PubMed ID: 30953479
[TBL] [Abstract][Full Text] [Related]
9. Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro.
Ki MK; Jeoung MH; Choi JR; Rho SS; Kwon YG; Shim H; Chung J; Hong HJ; Song BD; Lee S
Oncogene; 2013 Nov; 32(48):5449-57. PubMed ID: 23644659
[TBL] [Abstract][Full Text] [Related]
10. Proteomics-based screening of the endothelial heparan sulfate interactome reveals that C-type lectin 14a (CLEC14A) is a heparin-binding protein.
Sandoval DR; Gomez Toledo A; Painter CD; Tota EM; Sheikh MO; West AMV; Frank MM; Wells L; Xu D; Bicknell R; Corbett KD; Esko JD
J Biol Chem; 2020 Feb; 295(9):2804-2821. PubMed ID: 31964714
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis.
Lee S; Rho SS; Park H; Park JA; Kim J; Lee IK; Koh GY; Mochizuki N; Kim YM; Kwon YG
J Clin Invest; 2017 Feb; 127(2):457-471. PubMed ID: 27991863
[TBL] [Abstract][Full Text] [Related]
12. CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation.
Kim Y; Lee S; Zhang H; Lee S; Kim H; Kim Y; Won MH; Kim YM; Kwon YG
J Neuroinflammation; 2020 Feb; 17(1):48. PubMed ID: 32019570
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomics screen identifies a substrate repertoire of rhomboid protease RHBDL2 in human cells and implicates it in epithelial homeostasis.
Johnson N; Březinová J; Stephens E; Burbridge E; Freeman M; Adrain C; Strisovsky K
Sci Rep; 2017 Aug; 7(1):7283. PubMed ID: 28779096
[TBL] [Abstract][Full Text] [Related]
14. CLEC14a-HSP70-1A interaction regulates HSP70-1A-induced angiogenesis.
Jang J; Kim MR; Kim TK; Lee WR; Kim JH; Heo K; Lee S
Sci Rep; 2017 Sep; 7(1):10666. PubMed ID: 28878328
[TBL] [Abstract][Full Text] [Related]
15. C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation.
Khan KA; McMurray JL; Mohammed F; Bicknell R
FEBS J; 2019 Sep; 286(17):3299-3332. PubMed ID: 31287944
[TBL] [Abstract][Full Text] [Related]
16. CLEC14A protects against podocyte injury in mice with adriamycin nephropathy.
Su Z; Li Y; Lv H; Cui X; Liu M; Wang Z; Zhang Y; Zhen J; Tang W; Wang X; Yi F
FASEB J; 2021 Jul; 35(7):e21711. PubMed ID: 34107098
[TBL] [Abstract][Full Text] [Related]
17. Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.
Mura M; Swain RK; Zhuang X; Vorschmitt H; Reynolds G; Durant S; Beesley JF; Herbert JM; Sheldon H; Andre M; Sanderson S; Glen K; Luu NT; McGettrick HM; Antczak P; Falciani F; Nash GB; Nagy ZS; Bicknell R
Oncogene; 2012 Jan; 31(3):293-305. PubMed ID: 21706054
[TBL] [Abstract][Full Text] [Related]
18. Rhomboid-Like-2 Intramembrane Protease Mediates Metalloprotease-Independent Regulation of Cadherins.
Battistini C; Rehman M; Avolio M; Arduin A; Valdembri D; Serini G; Tamagnone L
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31783481
[TBL] [Abstract][Full Text] [Related]
19. RHBDL2 is a critical membrane protease for anoikis resistance in human malignant epithelial cells.
Cheng TL; Lai CH; Jiang SJ; Hung JH; Liu SK; Chang BI; Shi GY; Wu HL
ScientificWorldJournal; 2014; 2014():902987. PubMed ID: 24977233
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours.
Robinson J; Whitworth K; Jinks E; Nagy Z; Bicknell R; Lee SP
J Pathol Clin Res; 2020 Oct; 6(4):308-319. PubMed ID: 32696621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
